Astellas to acquire Ganymed for €422m

31-10-2016

Astellas to acquire Ganymed for €422m

Happy Stock Photo / shutterstock.com

Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million ($462 million).


Astellas, Ganymed, mergers & acquisition, Xtandi, cancer drugs

LSIPR